Auditing ultrasound assessment of fetal nuchal translucency thickness: A review of Australian national data 2002-2008

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 50, Issue 5, 2010, Pages 450-455

  Nisbet, Debbie L ^a   Robertson, Ann C ^b   Schluter, Philip J ^c   McLennan, Andrew C ^d   Hyett, Jon A ^e  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b Nuchal Translucency Ultrasound   (Australia)

^c AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^d Sydney Ultrasound for Women   (Australia)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Audit; Down syndrome screening; Nuchal translucency; Prenatal diagnosis; Ultrasound

Indexed keywords

ARTICLE; AUSTRALIA; CLINICAL ASSESSMENT; DATA BASE; ECHOGRAPHY; GESTATIONAL AGE; HEALTH EDUCATION; INTERNATIONAL STANDARD UNIT; MEDICAL AUDIT; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PRIVATE PRACTICE; QUALITY CONTROL; RETROSPECTIVE STUDY;

AUSTRALIA; CERTIFICATION; CLINICAL COMPETENCE; DOWN SYNDROME; EMPLOYEE PERFORMANCE APPRAISAL; FEMALE; HUMANS; MASS SCREENING; MEDICAL AUDIT; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 78650193767     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2010.01207.x     Document Type: Article

References (20)

1. Avgidou K, Papageorghiou A, Bindra R, Spencer K, Nicolaides KH. Prospective first-trimester screening for trisomy 21 in 30, 564 pregnancies. Am J Obstet Gynecol 2005;192:1761-1767.
2. O'Leary P, Breheny N, Dickinson JE et al. First-trimester combined screening for Down syndrome and other fetal anomalies. Obstet Gynecol 2006;107:869-876.
3. RANZCOG/HGSA College Statement. Statement No. C-Obs 4: prenatal screening tests for trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and neural tube defects. [Accessed 1 May 2009.] Available from URL: http://www.ranzcog.edu. au/publications/statements/C-obs4.pdf
4. UK National Screening Committee. Fetal Anomaly Screening Programme - Screening for Down's Syndrome: UK NSC Policy recommendations 2007-2010: model of Best Practice. Department of Health Policy Guideline No. DH-084731.
5. Crossley JA, Aitken DA, Cameron AD, McBride E, Connor JM. Combined ultrasound and biochemical screening for Down's Syndrome in the first trimester: a Scottish multicentre study. BJOG 2002;109:667-676.
6. Monni G, Zoppi MA, Ibba RM, Floris M. Fetal nuchal translucency test for Down's syndrome. Lancet 1997;350:1631.
7. RCOG. Recommendations arising from the 32nd Study Group: screening for Down syndrome in the first trimester. In: Grudzinskas J, Ward R, eds. Screening for Down Syndrome in the First Trimester. London: RCOG Press, 1997;353-356.
8. Herman A, Maymon R, Dreazen E, Caspi E, Bukovsky I, Weinraub Z. Nuchal translucency audit: a novel image-scoring method. Ultrasound Obstet Gynecol 1998;12:398-403.
9. Wojdemann KR, Christiansen M, Sundberg K, Larsen SO, Shalmi A, Tabor A. Quality assessment in prospective nuchal translucency screening for Down syndrome. Ultrasound Obstet Gynecol 2001;18:641-644.
10. Snijders RJ, Thom EA, Zachary JM et al. First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique. Ultrasound Obstet Gynecol 2002;19:353-359.
11. Australian Bureau of Statistics. Births, Australia, 2007. Canberra: ABS, 2008, ABS cat. no. 3301.0.
12. Fowkes FG. Medical audit cycle. A review of methods and research in clinical practice. Med Educ 1982;16:228-238.
13. Salomon LJ, Ville Y. The science and art of quality in obstetric ultrasound. Curr Opin Obstet Gynecol 2009;21:153-160.
14. Salomon LJ, Bernard M, Amarsy R, Bernard JP, Ville Y. The impact of crown-rump length measurement error on combined Down syndrome screening: a simulation study. Ultrasound Obstet Gynecol 2009;33:506-511.
15. Kagan KO, Wright D, Etchegaray A, Zhou Y, Nicolaides KH. Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21. Ultrasound Obstet Gynecol 2009;33:657-664.
16. Teoh M, Meagher SE, Choong S, Shekleton P, Wallace EM. The effect of image size on screen-positive rates for nuchal translucency screening. BJOG 2006;113:479-481.
17. Koster MPH, Wortelboer EJ, Engels MAJ et al. Quality of nuchal translucency measurements in The Netherlands: a quantitative analysis. Ultrasound Obstet Gynecol 2009;34:136-141.
18. Frey Tirri B, Troeger C, Holzgreve W, Tercanli S. Quality management of nuchal translucency measurement in residents. Ultraschall Med 2007;28:484-488.
19. Evans MI, Van Decruyes H, Nicolaides KH. Nuchal translucency measurements for first-trimester screening: the 'price' of inaccuracy. Fetal Diagn Ther 2007;22:401-404.
20. Schmidt P, Staboulidou I, Elsässer M, Vaske B, Hillemanns P, Scharf A. How imprecise may the measurement of fetal nuchal translucency be without worsening first-trimester screening? Fetal Diagn Ther 2008;24:291-295.